Cerebellar ataxia with glutamic acid decarboxylase autoantibodies
- 1 March 1999
- journal article
- case report
- Published by Wolters Kluwer Health in Neurology
- Vol. 52 (4) , 857
- https://doi.org/10.1212/wnl.52.4.857
Abstract
Article abstract Degenerative cerebellar ataxia with autoantibodies against glutamic acid decarboxylase (GAD) is a rare disorder and may represent a subset of ataxias previously classified as idiopathic. The authors report a patient with progressive cerebellar ataxia, insulin-dependent diabetes mellitus, and GAD antibodies who responded to IV immunoglobulins.Keywords
This publication has 10 references indexed in Scilit:
- Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunityNeurology, 1997
- Successful treatment of stiff man syndrome with intravenous immunoglobulin.Journal of Neurology, Neurosurgery & Psychiatry, 1997
- International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndromeJournal of the Neurological Sciences, 1997
- Glutamic Acid Decarboxylase – Gene to Antigen to DiseaseJournal of Internal Medicine, 1996
- Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type IJournal of Clinical Endocrinology & Metabolism, 1996
- Autoantibodies to Glutamate Decarboxylase in a Patient With Cerebellar Cortical Atrophy, Peripheral Neuropathy, and Slow Eye MovementsArchives of Neurology, 1995
- Treatment of stiff‐man syndrome with intravenous immunoglobulinNeurology, 1994
- Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylaseNature, 1990
- Autoantibodies to GABA-ergic Neurons and Pancreatic Beta Cells in Stiff-Man SyndromeNew England Journal of Medicine, 1990
- Selective Extraction of Small and Large Molecules from the Cerebrospinal Fluid by Purkinje NeuronsScience, 1985